LEAD-BURDENED TYPE 2 DIABETIC NEPHROPATHY

Clinical trials for LEAD-BURDENED TYPE 2 DIABETIC NEPHROPATHY explained in plain language.

Never miss a new study

Get alerted when new LEAD-BURDENED TYPE 2 DIABETIC NEPHROPATHY trials appear

Sign up with your email to follow new studies for LEAD-BURDENED TYPE 2 DIABETIC NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a Lead-Clearing drug protect kidneys in diabetes?

Disease control Not yet recruiting

This study tests whether a drug that removes lead from the blood can slow the worsening of kidney function in people with type 2 diabetes who also have higher-than-normal lead levels. Participants receive intravenous infusions of calcium disodium edetate, and their kidney functio…

Matched conditions: LEAD-BURDENED TYPE 2 DIABETIC NEPHROPATHY

Phase: NA • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC

LEAD-BURDENED TYPE 2 DIABETIC NEPHROPATHY

Get alerted when new LEAD-BURDENED TYPE 2 DIABETIC NEPHROPATHY trials appear

Could a Lead-Clearing drug protect kidneys in diabetes?